Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.

A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion. . 2013 Sep; 14(9):853-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.